Skip to main content
Fig. 3 | Pediatric Rheumatology

Fig. 3

From: Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study

Fig. 3

Time course of JADAS-27 scores and disease activity status. The mean (SD) JADAS-27 scores over time in overall patients (a) and patients who were newly treated with abatacept (b) are shown. The disease activity status based on JADAS-27 over time in overall patients (c) and patients who were newly treated with abatacept (d) are shown. A paired t-test was used for statistical analysis, with P < 0.05 considered to indicate statistical significance. An asterisk (*) indicates a significant difference was found when compared with baseline. JADAS, Juvenile Arthritis Disease Activity Score; ESR, erythrocyte sedimentation rate

Back to article page

Pediatric Rheumatology

ISSN: 1546-0096